Gelteq Ltd
Research Gelteq Ltd (GELS) on Bullrun: market cap USD 5.58M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerGELS
- ExchangeNASDAQ
- CountryAustralia
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Market capUSD 5.58M
- Financial periodQ2 2026
- RevenueAUD 90.00K
- Net income-AUD 1.87M
- Gross margin100.0%
Valuation Snapshot
latest market cap is USD 5.58M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | AUD 165.65K | -AUD 6.65M | -AUD 6.16M | 181.1% | -0.72 | AUD 344.65K | AUD 4.22M | AUD 15.80M |
| FY2024 | AUD 0 | -AUD 3.55M | -AUD 1.22M | n/a | -0.38 | AUD 24.52K | AUD 3.84M | AUD 15.11M |
| FY2023 | AUD 79.84K | -AUD 3.51M | -AUD 1.85M | 38.7% | -0.37 | AUD 399.22K | AUD 2.49M | AUD 18.66M |
| FY2022 | AUD 147.54K | -AUD 3.37M | -AUD 1.51M | 35.7% | -0.36 | AUD 162.49K | AUD 1.51M | AUD 20.86M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 5.58M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 8.57M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 22.39M | n/a | n/a | n/a |
About Gelteq Ltd
Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America, China and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Gelteq Ltd's market cap?
Gelteq Ltd's market capitalization is USD 5.58M.
What does Gelteq Ltd do?
Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America, China and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.